Riyan Alifbi Putera Irsal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Riyan Alifbi Putera Irsal has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Gusnia Meilin Gholam
Department of Biochemistry, Faculty of Mathematics and Natural Sciences, IPB University, Dramaga Campus, Bogor, 16680, Indonesia
6 shared publications - Maheswari Alfira Dwicesaria
IPB University
5 shared publications - Fernanda Chairunisa
Nasional University
4 shared publications Dzikri Anfasa Firdaus
Sultan Ageng Tirtayasa University
2 shared publications- Fachrur Rizal Mahendra
Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor agricultural University
2 shared publications Tiyara F. Mansyah
Bogor Agr Univ, Fac Math & Nat Sci, Dept Biochem, Bogor, Indonesia
2 shared publications
Latest Publications
- Open Access
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Unveiling the Antitumor Potential of Eugenia calycina Fruit: In silico Exploration of NUDT Enzyme and Estrogen Receptor Alpha Inhibition
Estrogen receptor alpha (ERα) and NUDT5 overexpression are hallmarks of aggressive breast cancer, associated with poor prognosis and therapeutic resistance. This study investigates Eugenia calycina, a plant rich in bioactive compounds, for its potential as an anti-breast cancer agent. We focus on its effects on ERα and NUDT5, an enzyme involved in cancer progression. This study combines molecular docking, DFT, and MD simulations to evaluate Eugenia calycina’s phytochemicals for targeting ERα and NUDT5. The results indicate that PDB2 exhibits superior binding stability compared to reference compounds, as evidenced by lower RMSDbackbone and RMSF values in molecular dynamics simulations. Furthermore, MM-PBSA calculations revealed significantly more negative binding free energies for PDB2 with both NUDT5 and ERα, suggesting stronger interactions. Quantum chemical calculations provided insights into the electronic properties of the compounds, revealing PDB2's potential for favourable interactions due to its smaller HOMO-LUMO energy gap. DFT analysis assessed stability, showing comparable values for the investigated compounds. Molecular docking reveals promising binding affinities of phytochemicals, particularly procyanidin dimer B2. Computational analysis and MD simulation revealed superior stability to reference compounds. While initial predictions indicate a favourable safety profile, further experimental validation is crucial to confirm these findings and their therapeutic potential.
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Open AccessUnveiling the Antitumor Potential of Eugenia calycina Fruit: In silico Exploration of NUDT Enzyme and Estrogen Receptor Alpha Inhibition
Estrogen receptor alpha (ERα) and NUDT5 overexpression are hallmarks of aggressive breast cancer, associated with poor prognosis and therapeutic resistance. This study investigates Eugenia calycina, a plant rich in bioactive compounds, for its potential as an anti-breast cancer agent. We focus on its effects on ERα and NUDT5, an enzyme involved in cancer progression. This study combines molecular docking, DFT, and MD simulations to evaluate Eugenia calycina’s phytochemicals for targeting ERα and NUDT5. The results indicate that PDB2 exhibits superior binding stability compared to reference compounds, as evidenced by lower RMSDbackbone and RMSF values in molecular dynamics simulations. Furthermore, MM-PBSA calculations revealed significantly more negative binding free energies for PDB2 with both NUDT5 and ERα, suggesting stronger interactions. Quantum chemical calculations provided insights into the electronic properties of the compounds, revealing PDB2's potential for favourable interactions due to its smaller HOMO-LUMO energy gap. DFT analysis assessed stability, showing comparable values for the investigated compounds. Molecular docking reveals promising binding affinities of phytochemicals, particularly procyanidin dimer B2. Computational analysis and MD simulation revealed superior stability to reference compounds. While initial predictions indicate a favourable safety profile, further experimental validation is crucial to confirm these findings and their therapeutic potential.
- Open Access
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Computational Evaluation of Sea Buckthorn Phytochemicals as CDPK3 and CDPK4 Inhibitors against Plasmodium falciparum
Malaria remains a primary global health concern, and targeting proteins from the calcium-dependent protein kinase (CDPK) family of Plasmodium falciparum represents a novel and promising therapeutic strategy. In this study, we investigated the molecular interactions between sea buckthorn-derived compounds and P. falciparum CDPK3 and CDPK4 to address the unexplored antimalarial potential of this traditionally used medicinal plant. The active sites of each CDPK protein were predicted to facilitate docking analysis. In silico assessments of absorption, distribution, metabolism, and excretion (ADME), along with PASS, were used to evaluate drug-likeness properties and antiprotozoal potential. Density functional theory (DFT) calculations were performed to predict the electronic reactivity of potential inhibitors, and molecular dynamics (MD) simulations were used to evaluate complex stability. The results showed that the active sites of CDPK3 and CDPK4 were successfully identified, with 39 amino acid residues for CDPK3 and 105 for CDPK4. Molecular docking analyses demonstrated favorable binding affinities, ranging from 4.026 to 8.917 kcal/mol for the CDPK3–ligand complexes and from 5.072 to 11.09 kcal/mol for the CDPK4–ligand complexes. Among all evaluated compounds, oleanolic acid and ursolic acid exhibited the highest predicted drug-likeness and strong antiprotozoal activity, as supported by PASS predictions. DFT calculations further reinforced their inhibitory potential, with both compounds showing an extremely small energy gap difference of −0.0002 eV. In addition, MD simulations using normal mode analysis (NMA) showed that the candidate inhibitors formed stable complexes with both CDPK3 and CDPK4.
- 15 February 2026
- Published by AMG Transcend Association in Biointerface Research in Applied Chemistry
- Vol. 16 (1)
Open AccessComputational Evaluation of Sea Buckthorn Phytochemicals as CDPK3 and CDPK4 Inhibitors against Plasmodium falciparum
Malaria remains a primary global health concern, and targeting proteins from the calcium-dependent protein kinase (CDPK) family of Plasmodium falciparum represents a novel and promising therapeutic strategy. In this study, we investigated the molecular interactions between sea buckthorn-derived compounds and P. falciparum CDPK3 and CDPK4 to address the unexplored antimalarial potential of this traditionally used medicinal plant. The active sites of each CDPK protein were predicted to facilitate docking analysis. In silico assessments of absorption, distribution, metabolism, and excretion (ADME), along with PASS, were used to evaluate drug-likeness properties and antiprotozoal potential. Density functional theory (DFT) calculations were performed to predict the electronic reactivity of potential inhibitors, and molecular dynamics (MD) simulations were used to evaluate complex stability. The results showed that the active sites of CDPK3 and CDPK4 were successfully identified, with 39 amino acid residues for CDPK3 and 105 for CDPK4. Molecular docking analyses demonstrated favorable binding affinities, ranging from 4.026 to 8.917 kcal/mol for the CDPK3–ligand complexes and from 5.072 to 11.09 kcal/mol for the CDPK4–ligand complexes. Among all evaluated compounds, oleanolic acid and ursolic acid exhibited the highest predicted drug-likeness and strong antiprotozoal activity, as supported by PASS predictions. DFT calculations further reinforced their inhibitory potential, with both compounds showing an extremely small energy gap difference of −0.0002 eV. In addition, MD simulations using normal mode analysis (NMA) showed that the candidate inhibitors formed stable complexes with both CDPK3 and CDPK4.
- Open Access
- 12 December 2024
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 19 (6) , 1165-1180
Computational exploration of palmitoyl-protein thioesterase 1 inhibition by Juniperus phoenicea L. for anti-dementia treatment
- 12 December 2024
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 19 (6) , 1165-1180
Open AccessComputational exploration of palmitoyl-protein thioesterase 1 inhibition by Juniperus phoenicea L. for anti-dementia treatment
- Open Access
- 19 September 2024
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 19 (5) , 947-960
Exploring the potential of Scabiosa columbaria in Alzheimer's disease treatment: An in silico approach
- 19 September 2024
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 19 (5) , 947-960
Open AccessExploring the potential of Scabiosa columbaria in Alzheimer's disease treatment: An in silico approach
- Open Access
- 30 May 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (2) , 161-171
Molecular Docking and Dynamics of Xylocarpus granatum as A Potential Parkinson’s Drug Targeting Multiple Enzymes
Parkinson's disease is a global health challenge affecting over 10 million individuals worldwide, leading to increased disability-adjusted life years (DALYs) and a rise in mortality rates. This study explores the potential anti-Parkinson's properties of Xylocarpus granatum, focusing on its interaction with key enzymes associated with the disease: catechol-O-methyltransferase (COMT), adenosine A2A receptor (A2AR), and monoamine oxidase-B (MAO-B). Using molecular docking and molecular dynamics approaches with YASARA Structure, the ethanol extract of X. granatum was investigated for its mechanism of action. Among 30 compounds, five demonstrated promising binding affinities. Structural flexibility analysis revealed minimal fluctuations in active-site residues, highlighting the stability of key complexes involving kaempferol, epicatechin, epigallocatechin, and native ligands. Molecular Mechanics Poisson–Boltzmann Surface Area (MM-PBSA) simulations provided insights into the binding energy of these complexes. Notably, kaempferol exhibited higher binding energy than the natural ligand, suggesting superior binding affinity. Analysis of the average radius of gyration (Rg) showcased control drug-MAO-B exhibited higher Rg values, indicating a more flexible protein conformation. Confirming mode stability with root mean square deviation (RMSD) analysis shows overall stability, except in the A2AR-bound complex. The study's collective findings underscore the structural stabilization of ligand-protein complexes, contributing valuable insights into the potential anti-Parkinson's properties of X. granatum. These discoveries hold promise for developing more effective therapies for Parkinson's disease and significantly contribute to the neurology field.
- 30 May 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (2) , 161-171
Open AccessMolecular Docking and Dynamics of Xylocarpus granatum as A Potential Parkinson’s Drug Targeting Multiple Enzymes
Parkinson's disease is a global health challenge affecting over 10 million individuals worldwide, leading to increased disability-adjusted life years (DALYs) and a rise in mortality rates. This study explores the potential anti-Parkinson's properties of Xylocarpus granatum, focusing on its interaction with key enzymes associated with the disease: catechol-O-methyltransferase (COMT), adenosine A2A receptor (A2AR), and monoamine oxidase-B (MAO-B). Using molecular docking and molecular dynamics approaches with YASARA Structure, the ethanol extract of X. granatum was investigated for its mechanism of action. Among 30 compounds, five demonstrated promising binding affinities. Structural flexibility analysis revealed minimal fluctuations in active-site residues, highlighting the stability of key complexes involving kaempferol, epicatechin, epigallocatechin, and native ligands. Molecular Mechanics Poisson–Boltzmann Surface Area (MM-PBSA) simulations provided insights into the binding energy of these complexes. Notably, kaempferol exhibited higher binding energy than the natural ligand, suggesting superior binding affinity. Analysis of the average radius of gyration (Rg) showcased control drug-MAO-B exhibited higher Rg values, indicating a more flexible protein conformation. Confirming mode stability with root mean square deviation (RMSD) analysis shows overall stability, except in the A2AR-bound complex. The study's collective findings underscore the structural stabilization of ligand-protein complexes, contributing valuable insights into the potential anti-Parkinson's properties of X. granatum. These discoveries hold promise for developing more effective therapies for Parkinson's disease and significantly contribute to the neurology field.
- Open Access
- 12 April 2024
- Published by MDPI AG in Proceedings
- Vol. 103 (1) , 66
In Silico Study of Combined Docking and Molecular Dynamics Simulation for Hops (Humulus lupulus) Active Compounds in Inhibiting Duffy-Binding Protein (DBP) as Anti-Plasmodium vivax (P. vivax)
Malaria is one of the infectious illnesses causing a public health burden worldwide. Plasmodium vivax (P. vivax) is the most prevalent malaria parasite in Asia and Asia Pacific. P. vivax is resistant to sulfadoxine–pyrimethamine (SP) and mefloquine. This resistance makes it extremely difficult to control and eradicate due to its ability to survive in the liver and reactivate if the person infected has a weakened immune system. Thus, this study aims to inhibit P. vivax via targeting Duffy-binding protein (DBP) with active compounds from Hops (Humulus lupulus). The inhibition of DBP is essential to reduce malaria invasion of human red blood cells. We performed a quality assessment and prediction of the active site of DBP to determine the effectiveness and prediction of ligands in inhibiting DBP. Furthermore, the mechanism and structural stability of active compounds against DBP were evaluated using a combination of molecular docking and molecular dynamics simulation and a density-functional theory (DFT) study. The results showed that rutin had the highest binding of 8.852 kcal/mol. However, after the molecular dynamics simulation was run for 50 ns, the ligand 6-prenylnaringenin via MM-PBSA calculation showed the most positive value of 106.760 kJ/mol. In addition, 6-prenylnaringenin is the most stable ligand via the analysis of root-mean-square deviation backbone (RMSDBb), root-mean-square deviation c-alpha (RMSDCa), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and the hydrogen bond formation. We conclude that 6-prenylnaringenin has a tight and stable bond with the targeted DBP protein. Finally, we propose the use of 6-prenylnaringenin as a potential antimalarial compound via in silico studies.
- 12 April 2024
- Published by MDPI AG in Proceedings
- Vol. 103 (1) , 66
Open AccessIn Silico Study of Combined Docking and Molecular Dynamics Simulation for Hops (Humulus lupulus) Active Compounds in Inhibiting Duffy-Binding Protein (DBP) as Anti-Plasmodium vivax (P. vivax)
Malaria is one of the infectious illnesses causing a public health burden worldwide. Plasmodium vivax (P. vivax) is the most prevalent malaria parasite in Asia and Asia Pacific. P. vivax is resistant to sulfadoxine–pyrimethamine (SP) and mefloquine. This resistance makes it extremely difficult to control and eradicate due to its ability to survive in the liver and reactivate if the person infected has a weakened immune system. Thus, this study aims to inhibit P. vivax via targeting Duffy-binding protein (DBP) with active compounds from Hops (Humulus lupulus). The inhibition of DBP is essential to reduce malaria invasion of human red blood cells. We performed a quality assessment and prediction of the active site of DBP to determine the effectiveness and prediction of ligands in inhibiting DBP. Furthermore, the mechanism and structural stability of active compounds against DBP were evaluated using a combination of molecular docking and molecular dynamics simulation and a density-functional theory (DFT) study. The results showed that rutin had the highest binding of 8.852 kcal/mol. However, after the molecular dynamics simulation was run for 50 ns, the ligand 6-prenylnaringenin via MM-PBSA calculation showed the most positive value of 106.760 kJ/mol. In addition, 6-prenylnaringenin is the most stable ligand via the analysis of root-mean-square deviation backbone (RMSDBb), root-mean-square deviation c-alpha (RMSDCa), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and the hydrogen bond formation. We conclude that 6-prenylnaringenin has a tight and stable bond with the targeted DBP protein. Finally, we propose the use of 6-prenylnaringenin as a potential antimalarial compound via in silico studies.